Cite
HARVARD Citation
Papi, M. et al. (2017). Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. Nanoscale. 9 (29), pp. 10327-10334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Papi, M. et al. (2017). Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. Nanoscale. 9 (29), pp. 10327-10334. [Online].